Literature DB >> 2402793

The impact of extended preservation on clinical liver transplantation.

R J Stratta1, R P Wood, A N Langnas, R M Duckworth, R S Markin, W Marujo, G L Grazi, S Saito, I Dawidson, L F Rikkers.   

Abstract

The introduction of UW solution into clinical transplantation has permitted extended cold storage preservation of the liver. Over a 46-month period, we have performed 308 orthotopic liver transplants (266 primary, 42 retransplants) in 266 recipients. Our experience is divided into cold-storage preservation in Eurocollins (163 transplants in 140 recipients) and UW (145 transplants in 131 recipients) solutions. Donor and recipient factors were comparable between the two groups. The use of UW solution has permitted an increase in the mean preservation time from 5.2 +/- 1.0 [EC] to 12.8 +/- 4.3 [UW] hr (P less than 0.001). The mean total operating time was reduced but intraoperative blood loss was unchanged with UW preservation. The number of transplants performed during the daytime hours has increased dramatically (21.5% [EC] vs. 71% [UW], P less than 0.001). The incidence of primary nonfunction, hepatic artery thrombosis, 1-month graft survival, and early retransplantation were similar in the 2 groups. Initial allograft function as determined by bile production, histology, and clinical assessment were likewise similar. Mean serum bilirubin, transaminase, and prothrombin levels were virtually identical by 5 days posttransplant. The enhanced margin of safety afforded by extended preservation has increased the capability for distant organ procurement and sharing, minimized organ wastage, and improved the efficiency of organ retrieval. With the relaxation of logistical constraints, our rate of liver import has nearly doubled (20.9% [EC] vs. 39.3% [UW], P less than 0.001). Extended preservation has permitted the development of reduced-size liver grafting (n = 12), resulting in a significant reduction in the number of deaths occurring while awaiting transplantation. Therefore, we advocate the use of UW solution with selective extension of preservation based not only on donor and recipient factors but also on manpower, resource, and logistical considerations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402793     DOI: 10.1097/00007890-199009000-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Current protective strategies in liver surgery.

Authors:  Kurinchi S Gurusamy; Hector D Gonzalez; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation.

Authors:  T P Theruvath; C Czerny; V K Ramshesh; Z Zhong; K D Chavin; J J Lemasters
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

3.  Trimetazidine: is it a promising drug for use in steatotic grafts?

Authors:  Ismail Ben Mosbah; Araní Casillas-Ramírez; Carme Xaus; Anna Serafín; Joan Roselló-Catafau; Carmen Peralta
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

4.  Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis.

Authors:  James E Stahl; Jennifer E Kreke; Fawaz Ali Abdul Malek; Andrew J Schaefer; Joseph Vacanti
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.